主要为中小型生物技术公司提供临床研发外包服务的美国合同研究组织(CRO)Medpace刚刚公布的财报业绩强劲,股价大涨。美东时间7月22日周二,Medpace股价(MEDP)跳空高开逾44%,早盘涨幅一度扩大到62.3%,后涨幅有所收窄,收涨近54.7%,创收盘最高纪录,并创上市将近九年来最大单日涨幅。Medpace股价暴涨也带飞了CRO概念股。周二Iqvia Holdings(IQV)收涨近...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.